troglitazone has been researched along with Uterine Neoplasms in 2 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
Uterine Neoplasms: Tumors or cancer of the UTERUS.
Excerpt | Relevance | Reference |
---|---|---|
"Human leiomyomas were also found to express all three PPAR isoforms, and primary cultures of these cells were sensitive to the inhibitory effects of PPARgamma ligands." | 1.32 | Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma. ( Broaddus, RR; Copland, JA; Fischer, SM; Gottardis, MM; Houston, KD; Walker, CL, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Houston, KD | 1 |
Copland, JA | 1 |
Broaddus, RR | 1 |
Gottardis, MM | 1 |
Fischer, SM | 1 |
Walker, CL | 1 |
Tsibris, JC | 1 |
Porter, KB | 1 |
Jazayeri, A | 1 |
Tzimas, G | 1 |
Nau, H | 1 |
Huang, H | 1 |
Kuparadze, K | 1 |
Porter, GW | 1 |
O'Brien, WF | 1 |
Spellacy, WN | 1 |
2 other studies available for troglitazone and Uterine Neoplasms
Article | Year |
---|---|
Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma.
Topics: Animals; Cell Division; Chromans; Docosahexaenoic Acids; Estradiol; Female; Humans; Leiomyoma; Ligan | 2003 |
Human uterine leiomyomata express higher levels of peroxisome proliferator-activated receptor gamma, retinoid X receptor alpha, and all-trans retinoic acid than myometrium.
Topics: Alitretinoin; Animals; Carcinogens; Chromans; Drug Implants; Estradiol; Female; Guinea Pigs; Humans; | 1999 |